You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 4, July 23, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Health Policy
 •Law and Medicine
 •Statistics and Research Methods
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

UK Licenses Human Embryo Creation

"Dolly" Cloner to Create Embryos for Research

Brian Vastag

JAMA. 2003;290:449-450.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The United Kingdom (UK) has granted a license to Roslin Institute, Edinburgh, Scotland, to create human embryos for stem cell research via parthenogenesis, a "virgin birth" technique that jolts oocytes into a fertilized state without sperm. The license also allows the institute—former home of Dolly the sheep, which died in February—and its lead cloning researcher, Ian Wilmut, PhD, to derive stem cells from embryos created for in vitro fertilization (IVF) .


These nonhuman primate eggs have developed into 8-day-old embryos via a process called parthenogenesis (Science. 2002;295:819) (Photo credit: AAAS)

It is the fourth license for embryonic stem cell research handed out by the government of the United Kingdom, but the first license allowing the creation of human embryos by any means.


AN AID TO RESEARCH

Speaking at the National Institutes of Health, Bethesda, Md, Wilmut said that he supports research on all types of stem . . . [Full Text of this Article]

SUCCESS IN PRIMATES



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.